Virtus Biotech Clinical Trials Etf (BBC)
$44.61
▲ +0.05 (+0.10%)
1-day change
$43.63 – $56.18
52-week range
Top 10 holdings weight14.25%
Effective number of positions108.2
Positions above 1%10
Net assets
$46.4M
Holdings
132
As of
July 31, 2026
BBC Stock Price Chart Daily OHLCV with technical indicators — pan, zoom, and customize your view
range
bars
Bar granularity adapts to the selected period — hover the chart to see open/high/low/close for a bar.
Performance as of Oct. 5, 2026
| Period | Price return | Total return |
|---|---|---|
| 1M | ▼ -16.94% | ▼ -16.94% |
| 3M | · | · |
| 6M | · | · |
| YTD | · | · |
| 1Y | · | · |
| 3Y | · | · |
| 5Y | · | · |
| Max | ▼ -17.10% | ▼ -17.10% |
Volatility 1Y·
Volatility 3Y·
Max drawdown 3Y
·
Beta 3Y·
Sharpe 1Y*·
Total return assumes dividends are reinvested. Returns are not benchmarked against an index. * Sharpe ratio is computed with a 0% risk-free rate.
Fund flows (SEC-reported)
Last month (Jul 2026)
+$161K
Quarter ending Jul 2026
+$5.1M
Trailing 12 months
+$11.7M
Based on the fund's own SEC Form N-PORT monthly flow disclosures (Item C.9 "Flow Information") — sales minus redemptions, reinvested distributions excluded. This is a different, independent metric from the "Net flows" estimate above (which is derived from daily shares-outstanding changes). SEC N-PORT filing lag is up to ~60 days; the most recent month/quarter may not yet be fully reflected.
Full composition 132 holdings
| Name | CUSIP | Value | % | Balance | Category | Country |
|---|---|---|---|---|---|---|
| DREYFUS GOVERNMENT CASH MANAGE | · | $1.6M | 3.48 | 1,612,819 | STIV | US |
| FIRST TRACKS BIOTHERAPEUTICS INC | 337185102 | $776K | 1.67 | 17,620 | EC | US |
| MBX BIOSCIENCES INC | 55287L101 | $577K | 1.24 | 8,754 | EC | US |
| ATAIBECKLEY INC | 04650F101 | $569K | 1.23 | 79,289 | EC | US |
| MONOPAR THERAPEUTICS INC | 61023L207 | $563K | 1.21 | 5,200 | EC | US |
| DEFINIUM THERAPEUTICS INC | 24477V105 | $547K | 1.18 | 12,558 | EC | CA |
| XENCOR INC | 98401F105 | $509K | 1.10 | 25,208 | EC | US |
| ZENAS BIOPHARMA INC | 98937L105 | $494K | 1.06 | 15,697 | EC | US |
| UNIQURE NV | · | $492K | 1.06 | 11,273 | EC | NL |
| APOGEE THERAPEUTICS INC | 03770N101 | $472K | 1.02 | 3,519 | EC | US |
| VOR BIOPHARMA INC | 929033207 | $458K | 0.99 | 21,644 | EC | US |
| REGENXBIO INC | 75901B107 | $452K | 0.97 | 46,670 | EC | US |
| LB PHARMACEUTICALS INC | 50180M108 | $438K | 0.94 | 10,936 | EC | US |
| DAMORA THERAPEUTICS INC | · | $434K | 0.93 | 14,957 | EC | KY |
| AMYLYX PHARMACEUTICALS INC | 03237H101 | $433K | 0.93 | 21,303 | EC | US |
| DYNE THERAPEUTICS INC | 26818M108 | $430K | 0.93 | 17,087 | EC | US |
| ORUKA THERAPEUTICS INC | 687604108 | $429K | 0.93 | 4,447 | EC | US |
| NURIX THERAPEUTICS INC | 67080M103 | $426K | 0.92 | 18,337 | EC | US |
| ORIC PHARMACEUTICALS INC | 68622P109 | $416K | 0.90 | 37,585 | EC | US |
| GH RESEARCH PLC | · | $413K | 0.89 | 14,716 | EC | IE |
| SIONNA THERAPEUTICS INC | 829401108 | $408K | 0.88 | 8,653 | EC | US |
| DIANTHUS THERAPEUTICS INC | 252828108 | $405K | 0.87 | 3,787 | EC | US |
| ERASCA INC | 29479A108 | $402K | 0.87 | 22,122 | EC | US |
| JADE BIOSCIENCES INC | 008064206 | $400K | 0.86 | 20,261 | EC | US |
| SELLAS LIFE SCIENCES GROUP INC | 81642T209 | $397K | 0.86 | 39,695 | EC | US |
| PALVELLA THERAPEUTICS INC | 697947109 | $397K | 0.86 | 2,856 | EC | US |
| RELAY THERAPEUTICS INC | 75943R102 | $395K | 0.85 | 20,989 | EC | US |
| REPLIMUNE GROUP INC | 76029N106 | $392K | 0.84 | 35,001 | EC | US |
| ALTO NEUROSCIENCE INC | 02157Q109 | $392K | 0.84 | 14,476 | EC | US |
| ADLAI NORTYE LTD | 00704R109 | $392K | 0.84 | 30,117 | EC | KY |
| BICARA THERAPEUTICS INC | 055477103 | $388K | 0.84 | 14,331 | EC | US |
| IMMUNOME INC | 45257U108 | $385K | 0.83 | 16,911 | EC | US |
| AVALO THERAPEUTICS INC | 05338F306 | $384K | 0.83 | 21,058 | EC | US |
| MEIRAGTX HOLDINGS PLC | · | $382K | 0.82 | 32,410 | EC | KY |
| IDEAYA BIOSCIENCES INC | 45166A102 | $381K | 0.82 | 10,725 | EC | US |
| SPYGLASS PHARMA INC | 85220G109 | $380K | 0.82 | 16,855 | EC | US |
| KODIAK SCIENCES INC | 50015M109 | $379K | 0.82 | 9,125 | EC | US |
| REVOLUTION MEDICINES INC | 76155X100 | $379K | 0.82 | 2,020 | EC | US |
| CELLDEX THERAPEUTICS INC | 15117B202 | $378K | 0.82 | 9,940 | EC | US |
| SPYRE THERAPEUTICS INC | 00773J202 | $378K | 0.82 | 3,847 | EC | US |
| CULLINAN THERAPEUTICS INC | 230031106 | $374K | 0.81 | 22,687 | EC | US |
| LEXICON PHARMACEUTICALS INC | 528872302 | $374K | 0.81 | 161,882 | EC | US |
| XENON PHARMACEUTICALS INC | 98420N105 | $374K | 0.81 | 5,966 | EC | CA |
| KYMERA THERAPEUTICS INC | 501575104 | $373K | 0.80 | 3,605 | EC | US |
| BIOHAVEN LTD | · | $372K | 0.80 | 27,554 | EC | VG |
| CG ONCOLOGY INC | 156944100 | $371K | 0.80 | 5,218 | EC | US |
| NEKTAR THERAPEUTICS | 640268306 | $370K | 0.80 | 5,234 | EC | US |
| ENLIVEN THERAPEUTICS INC | 29337E102 | $369K | 0.80 | 6,738 | EC | US |
| ARCUS BIOSCIENCES INC | 03969F109 | $368K | 0.79 | 13,060 | EC | US |
| TYRA BIOSCIENCES INC | 90240B106 | $367K | 0.79 | 11,516 | EC | US |
Sector breakdown
Dividends 5 payments
1.47%TTM yield
$0.66TTM payout / share
Irregular
(est.)
| Ex-date | Amount / share |
|---|---|
| Dec. 22, 2025 | $0.6550 |
| Dec. 20, 2024 | $0.2400 |
| Dec. 20, 2023 | $0.0820 |
| Dec. 20, 2017 | $0.2970 |
| Dec. 21, 2015 | $0.1470 |
Institutional owners (13F) 20 filers
Institutions that report holding this ETF in their quarterly SEC Form 13F. Long positions only; a single filer may appear twice for separate option legs. Large offsetting put/call legs typically reflect market-making or hedged inventory, not directional conviction.
| Institution | Value | % of tracked 13F | Shares | Type | As of |
|---|---|---|---|---|---|
| Kera Capital Partners, Inc. | $5,321,454 | 25.25% | 101,003 | Shares | June 30, 2026 |
| WEALTH ENHANCEMENT ADVISORY SERVICES, LLC | $3,643,703 | 17.29% | 68,536 | Shares | June 30, 2026 |
| Militia Capital Management LLC | $2,405,805 | 11.41% | 45,663 | Shares | June 30, 2026 |
| CITADEL ADVISORS LLC | $2,251,593 | 10.68% | 42,736 | Shares | June 30, 2026 |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $2,052,650 | 9.74% | 38,960 | Shares | June 30, 2026 |
| Quantinno Capital Management LP | $1,212,254 | 5.75% | 23,009 | Shares | June 30, 2026 |
| Militia Capital Partners, LP | $1,205,501 | 5.72% | 31,263 | Shares | Dec. 31, 2025 |
| MORGAN STANLEY | $791,664 | 3.76% | 15,026 | Shares | June 30, 2026 |
| LPL Financial LLC | $649,567 | 3.08% | 12,329 | Shares | June 30, 2026 |
| GOLDMAN SACHS GROUP INC | $456,999 | 2.17% | 8,674 | Shares | June 30, 2026 |
| OSAIC HOLDINGS, INC. | $235,175 | 1.12% | 4,463 | Shares | June 30, 2026 |
| ENVESTNET ASSET MANAGEMENT INC | $234,348 | 1.11% | 4,448 | Shares | June 30, 2026 |
| Worth Asset Management, LLC | $215,644 | 1.02% | 4,093 | Shares | June 30, 2026 |
| Operose Advisors LLC | $119,808 | 0.57% | 2,274 | Shares | June 30, 2026 |
| UBS Group AG | $110,430 | 0.52% | 2,096 | Shares | June 30, 2026 |
| Institute for Wealth Management, LLC. | $99,577 | 0.47% | 1,890 | Shares | June 30, 2026 |
| Dynamic Wealth Strategies, LLC | $48,840 | 0.23% | 927 | Shares | June 30, 2026 |
| GROUP ONE TRADING LLC | $15,806 | 0.07% | 300 | Shares | June 30, 2026 |
| Federation des caisses Desjardins du Quebec | $5,795 | 0.03% | 110 | Shares | June 30, 2026 |
| Allworth Financial LP | $527 | 0.00% | 10 | Shares | June 30, 2026 |